Singular Genomics Teams Up with Vanderbilt to Revolutionize Gastric Pre-Cancer Analysis

Transforming Gastric Pre-Cancer Research

In a significant advancement for cancer research, Singular Genomics has partnered with the esteemed Vanderbilt University Medical Center (VUMC) to establish a dedicated Center of Excellence. This collaboration aims to enhance high-throughput spatial multimodal profiling in studies related to gastric pre-cancer.

The Need for Enhanced Data Analysis

As cancer research evolves, constructing detailed 3D atlases of cellular, molecular, and spatial features associated with cancer remains paramount. The Human Tumor Atlas Network (HTAN), supported by the National Cancer Institute (NCI), has been at the forefront of this initiative, striving to meticulously map the transition from precancerous conditions to full-blown malignancy. With this new partnership, both organizations aim to push the boundaries of what is scientifically possible.

High Throughput and Operational Efficiency

One of the most significant challenges in cancer research is the generation of robust, standardized datasets from diverse clinical specimens. The collaboration between Singular Genomics and VUMC will utilize Singular's innovative G4X™ Spatial Sequencer, known for its industry-leading throughput and accuracy, to drive cost-effective and scalable spatial multimodal profiling. The G4X platform provides integrated in situ readouts at scale, which includes advanced RNA, protein, and other essential profiling metrics. This capability is crucial for generating the large cohorts necessary for meaningful research outcomes.

Focus on the GAME3D Initiative

The VUMC is actively participating in HTAN's ambitious project named the Center for Gastric Pre-Cancer Atlas of Multidimensional Evolution in 3D (GAME3D). This initiative is aimed at creating comprehensive multimodal atlases that highlight crucial transitions in the evolution of gastric diseases. Emphasizing early lesions and utilizing longitudinal sampling, the GAME3D project intends to yield both 2D and 3D spatial atlases with single-cell resolution.

The Future of Cancer Research

The collaboration at this Center of Excellence leverages Singular Genomics' advanced technology to foster groundbreaking innovation in cancer data analysis. As emphasized by Josh Stahl, CEO at Singular, this partnership is set to propel forward the creation of datasets essential for studying the evolution of early gastric cancers. The combined resources and expertise of these two institutions herald a new chapter in cancer research, reflecting a commitment to improve patient outcomes through enhanced scientific discovery.

Dr. Tae Hyun Hwang, Endowed Director in AI Research at VUMC, noted the significance of this collaboration: “We are pleased to work with Singular Genomics to bolster our research into generating comprehensive 3D spatial multimodal datasets. We aim to share our findings within HTAN and the larger cancer research community.”

About the Partners

Singular Genomics, headquartered in San Diego, California, is dedicated to advancing high-throughput spatial pathology solutions that support precision medicine. The G4X™ Spatial Sequencer represents a leap in technology, enabling more efficient analysis and accelerating the translation of research into clinical applications.

Vanderbilt University Medical Center, located in Nashville, Tennessee, has a rich tradition of excellence in patient care, health professional education, and scientific research. The center operates a vast healthcare system, reporting over 3.2 million patient visits annually, underscoring its vital role in advancing healthcare.

Conclusion

The establishment of this Center of Excellence reveals a powerful commitment to tackling gastric pre-cancer with innovative technological solutions. The collaboration between Singular Genomics and VUMC is poised to significantly impact the landscape of cancer research, ultimately fostering advancements in precision medicine and improving patient care. As this initiative unfolds, the scientific community eagerly anticipates the insights that will emerge from this landmark partnership.